Report : Europe Enteral Nutrition Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Nasogastric, Nasoenteral, Sipping, and Others) and Country
UK is expected to witness fastest growth rate in Europe Enteral Nutrition Market during 2023–2031
According to our new research study on "Europe Enteral Nutrition Market Forecast to 2031 – Regional Analysis – by Product Type and Geography," the Europe enteral nutrition market was valued at US$ 3,322.95 million in 2023 and is projected to reach US$ 5,797.18 million by 2031; it is anticipated to record a CAGR of 7.2% from 2023 to 2031. An increase in the prevalence of gastrointestinal diseases and increasing cases of malnutrition are contributing to the growing Europe enteral nutrition market size. However, the complications associated with feeding systems hampers the market growth. Further, development of plant-based nutrition products are expected to emerge as new market trends in the coming years.
Europe Enteral Nutrition Market Analysis
According to the UK parliament, ~1 in 20 people was malnourished in the UK in 2022, while ~1 in 10 people aged 65 or above was suffering from the condition. People with chronic illnesses are more likely to suffer from malnutrition. Malnutrition is more prevalent in lower-income regions and households, and undernutrition is more prevalent among children from less affluent backgrounds. According to the British Dietic Association (BDA), within the UK, over 40,000 adults and children require home enteral feeding, which is typically the sole source of nutrition and hydration, and means of receiving essential medications. Oral nutritional supplements play a crucial role in both the treatment of specific diseases as well as the prevention of disease-related malnutrition in hospitals and the community.
Further, according to a Diabetes UK report, the UK had ~4.3 million diagnosed diabetic cases in 2022, and more than 2.4 million people were at elevated risk of developing type 2 diabetes in the UK. Enteral nutrition can help regulate nutrient intake, provide balanced nutrition, and support blood sugar control, aiding in weight maintenance.
Europe Enteral Nutrition Market Report Scope
Based on product type, the enteral nutrition market is segmented into nasogastric, nasoenteral, sipping, and others. The nasogastric segment held the largest share in 2023. Nasogastric feeding involves the insertion of a small tube into the stomach through the nose, offering a simple, cost-effective solution for providing nutrition to patients facing swallowing difficulties, neurological disorders, or severe conditions that impair oral intake. Diabetes often leads to malnutrition and increases the need for enteral feeding formulas. As per the World Health Organization(WHO), diabetes is among the common chronic conditions in the WHO European Region, and Europe has the highest burden of type 1 diabetes in the world. WHO estimated that 1 in 10 people living in the Region will have diabetes by 2045.
Nasogastric segment is further sub segmented into standard and disease specific. The standard segment held the largest share in 2023, however the disease specific segments id likely to witness fastest growth rate during the forecast period.
Nestlé, Danone S.A., Abbott Laboratories, Friesland Campina, Fresenius SE and Co. KGaA, B. Braun SE, Dr. Schär AG, Arla Food, Reckitt Benckiser, Perrigo Company PLC, Fonterra Co-operative Group Limited, Kate Farms, Bexen Medical, and Charing Cross Scientific AS are among the leading companies operating in the Europe enteral nutrition market.
Companies operating in the Europe enteral nutrition market adopt various organic and inorganic strategies. Organic strategies mainly include product launches and product approvals. Acquisitions, collaborations, and partnerships are among the inorganic growth strategies witnessed in the Europe enteral nutrition market. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, thereby contributing to the overall Europe enteral nutrition market growth. Further, acquisition and partnership strategies help them strengthen their customer base and expand their product portfolios. In March 2022, Vygon (a specialist single-use medical devices group) acquired Macatt Medica (a distribution company located in Peru). With the acquisition, Macatt Medica became a fully owned subsidiary of Vygon, supporting the latter’s operations in South America. Macatt Medica now distributes most of Vygon’s products in Peru, including a range of enteral nutrition products. In October 2020, Nutricia (part of Danone) acquired Real Food Blends. The company helps contribute to the real food blends mission and portfolio by bringing more unique and nutritious choices to children and adults dependent on feeding tubes.
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com